Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-02 Sale | 2021-09-07 7:17 pm | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 17,000 | $41.68 | $708,493 | 211,546 (Direct) | View |
| 2021-04-29 Sale | 2021-04-30 6:24 pm | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 3,295 | $40.29 | $132,765 | 8,073 (Direct) | View |
| 2021-04-08 Sale | 2021-04-15 7:12 pm | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 200 | $40 | $8,000 | 11,368 (Direct) | View |
| 2021-04-07 Sale | 2021-04-09 5:53 pm | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 828 | $40.08 | $33,188 | 11,568 (Direct) | View |
| 2020-09-29 Purchase | 2020-09-29 8:07 pm | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 3,750 | $19 | $71,250 | 3,750 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-09-02 Exercise | 2021-09-07 7:17 pm | N/A 2030-09-01 | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 17,000 | $0 | 211,546 (Direct) | View |
| 2021-09-02 Exercise | 2021-09-07 7:17 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 17,000 | $12.85 | 211,546 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-22 6:11 pm | N/A 2031-07-19 | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-04-29 Exercise | 2021-04-30 6:24 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 3,295 | $0 | 8,073 (Direct) | View |
| 2021-04-29 Exercise | 2021-04-30 6:24 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 3,295 | $1.89 | 8,073 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-15 7:12 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 200 | $0 | 11,368 (Direct) | View |
| 2021-04-08 Option Award | 2021-04-15 7:12 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 200 | $1.89 | 11,368 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 5:53 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 828 | $0 | 11,568 (Direct) | View |
| 2021-04-07 Option Award | 2021-04-09 5:53 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 828 | $1.89 | 11,568 (Direct) | View |
Ownership | 2020-09-24 7:26 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Pierce Christopher EVP and Chief of Business Oper | 0 | $0 | 332,870 (Direct) | View |